These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 10985216)

  • 21. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 24. High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
    Flamholc L; Haidl S; Westin E; Borgdalen L; Prellner T
    Infection; 1992; 20(6):309-12. PubMed ID: 1293048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD; Rimland D
    AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
    Teuscher AU; Opravil M; Theiler R; Speich R; Kuster H; Siegenthaler W; Russi EW; Lüthy R
    Clin Infect Dis; 1993 Apr; 16(4):519-22. PubMed ID: 8513058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
    Dorrell L; McCallum AK; Snow MH; Ong EL
    AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401
    [No Abstract]   [Full Text] [Related]  

  • 28. Bilateral pneumothoraces hasten mortality in AIDS patients receiving secondary prophylaxis with aerosolized pentamidine. Association with a lower Dco prior to receiving aerosolized pentamidine.
    Renzi PM; Corbeil C; Chassé M; Braidy J; Matar N
    Chest; 1992 Aug; 102(2):491-6. PubMed ID: 1643939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
    Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
    Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.
    Ioannidis JP; Dixon DO; McIntosh M; Albert JM; Bozzette SA; Schnittman SM
    Control Clin Trials; 1999 Jun; 20(3):253-66. PubMed ID: 10357498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
    Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
    Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pneumocystis carinii pneumonia in AIDS: retrospective analysis of 80 documented cases (1985-1993)].
    Morlat P; Bartou C; Ragnaud JM; Dequae L; Lacoste D; Buisson M; Bernard N; Mercié P; Couprie B; Beylot J; Aubertin J
    Rev Med Interne; 1996; 17(1):25-33. PubMed ID: 8677382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
    Rabaud C; May T; Beuscart C; Reynes J; Leport C; Canton P
    Ann Med Interne (Paris); 1998 Mar; 149(2):62-6. PubMed ID: 11490526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
    Easterbrook PJ
    Genitourin Med; 1997 Apr; 73(2):139-43. PubMed ID: 9215100
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
    Castellano AR; Nettleman MD
    JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis.
    Ewig S; Rockstroh JK; Seitz HM; Marklein G; Christ F; Lüchters G; Brackmann HH; Lüderitz B
    Respiration; 1993; 60(3):186-92. PubMed ID: 8210724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidine.
    Principi N; Marchisio P; Onorato J; Gabiano C; Galli L; Caselli D; Morandi B; Campelli A; Clerici M; Gattinara GC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):158-63. PubMed ID: 8680887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1995 Sep; 31(2):99-105. PubMed ID: 8666860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.
    Cain LE; Cole SR
    Stat Med; 2009 May; 28(12):1725-38. PubMed ID: 19347843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.